Global Pediatric Electrolyte Solution Market is poised to value over USD 1.5 billion by 2027

 

What is a pediatric electrolyte solution?

The pediatric electrolyte solution is designed to help sick children with rehydration and electrolyte replacement. This solution is used to replenish fluids and minerals lost as a result of diarrhoea and vomiting. It can be fed orally or through a tube; if the condition is severe, the solution is injected. The solutions are available in a variety of fruit flavours, including apple, grape, and cherry.

Market Outlook for Global pediatric electrolyte solution

The rising incidence of diarrhoea in children is expected to drive the growth of the pediatric electrolyte solution market. According to a World Health Organization (WHO) article published in September 2017, there were approximately 1.7 billion cases of childhood diarrheal disease worldwide each year.780 million people worldwide do not have access to safe drinking water, and 2.5 billion do not have access to adequate sanitation.

The global pediatric electrolyte solution market is expected to be worth US$ 987.7 million in 2020, with a CAGR of 6.2 per cent during the forecast period (2020-2027).

Pediatric patients are three times more likely to become dehydrated as a result of diarrhoea. Diarrhoea is still one of the leading causes of infant mortality, and electrolyte solutions are a one-stop solution. Complementary feeding before six months, inadequate handwashing facilities, use of an unimproved water source, infant rota vaccination status and use of a cup are all factors that increase the risk of diarrhoea.

Product introductions in North America are expected to boost the market growth.

North America is expected to hold the dominant position in the global pediatric electrolyte solution market, owing to increasing product launches in this region.

Pace Wellness, for example, launched Solves strips, a pediatric electrolyte oral thin-film, a disruptive innovation for medicine delivery, in April 2016. Pace Wellness uses an advanced, patented drug-delivery platform to make oral dissolvable pharmaceutical and nutraceutical products.

These pediatric electrolyte strips are formulated with a controlled dosage of essential electrolytes for children aged 2 and up to quickly replenish electrolytes and aid in fluid retention.

The COVID-19 outbreak and its severe impacts in numerous parts of the world have had an impact on enterprises of all types. The COVID-19 epidemic has had a significant impact on the private health industry.

As a result of the epidemic's lockdowns in numerous countries, the healthcare sector has been put under financial strain. As a result, the worldwide paediatric electrolyte solution market is likely to be constrained by the COVID-19 pandemic over the forecast period.

Medtronic, ANDOR n.v., Terumo Cardiovascular Systems Corporation, Sorin Group, MEDIVATORS Inc. and MAQUET Holding B.V. & Co. KG are some of the key players in the adult and pediatric hemoconcentration market.